ScreenerHero

XCUR Exicure, Inc.

NAS · US · Healthcare · Biotechnology · exicuretx.com
1.020USD-5.56%Mkt Cap: 6.68M $P/E: —

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiot…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap6.68M USD
Enterprise Value5.35M USD
Revenue (TTM)—
Gross Profit1.26M USD
Net Income (TTM)-4.95M USD
Revenue/Share—
Last Price1.020 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.40
PEG—
EV/EBITDA-0.75
EV/Revenue—
P/S—
P/B3.28
EPS (TTM)-1.31
EPS (Forward)-0.77
52W Range
1.0000% of range9.480
52W High9.480 USD
52W Low1.000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-125.98%
ROA-35.23%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.55M USD
CapEx (TTM)1.00K USD
FCF Margin—
FCF Yield-54.20%
Net Debt-1.72M USD
Net Debt/EBITDA0.24
Balance Sheet
Debt/Equity0.04
Current Ratio0.56
Quick Ratio0.41
Book Value/Sh0.33 USD
Cash/Share0.26 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateAug 28, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.55M
Float3.10M
Insiders41.47%
Institutions2.25%
Short Interest
Short Ratio1.5d
Short % Float2.20%
Short % Out.1.08%
Shares Short70.67K
Short (prev mo.)60.40K
Technical
SMA 501.343 (-24.0%)
SMA 2003.168 (-67.8%)
Beta3.64
S&P 52W Chg16.45%
Avg Vol (30d)31.38K
Avg Vol (10d)13.17K
Technical Indicators
RSI (14)31.7
MACD-0.0943
MACD Signal-0.0846
MACD Hist.-0.0098
BB Upper1.475 USD
BB Middle1.241 USD
BB Lower1.007 USD
BB Width37.69%
ATR (14)0.1080 USD
Vol Ratio (20d)0.32x